CDX2 and colorectal cancer: To this end, we obtained a Lovo colorectal cancer cell line devoid of CDX2 expression (LovoCDX2−/−) to test the role of CDX2/AS in alternative splicing in a physiologic setting and examine the impact of CDX2 expression on CDX2/AS splicing activity [23].